Holen Sie sich die Stockscreener-App
20.01
4.49%
-0.94
Handel nachbörslich:
20.01
Schlusskurs vom Vortag:
$20.95
Offen:
$20.96
24-Stunden-Volumen:
310.26K
Relative Volume:
0.60
Marktkapitalisierung:
$1.19B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-85.21M
KGV:
-10.59
EPS:
-1.89
Netto-Cashflow:
$-68.53M
1W Leistung:
-1.72%
1M Leistung:
+6.78%
6M Leistung:
+0.45%
1J Leistung:
-7.96%
1-Tages-Spanne:
$19.95
$21.02
1-Wochen-Bereich:
$19.92
$21.30
52-Wochen-Spanne:
$13.30
$30.03
Enliven Therapeutics Inc Stock (ELVN) Company Profile
Firmenname
Enliven Therapeutics Inc
Sektor
Branche
Telefon
720-647-8519
Adresse
6200 LOOKOUT ROAD, BOULDER
Vergleichen Sie ELVN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELVN
Enliven Therapeutics Inc
|
20.01 | 1.24B | 0 | -85.21M | -68.53M | -1.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Enliven Therapeutics Inc Stock (ELVN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-16 | Eingeleitet | Goldman | Buy |
| 2024-12-13 | Eingeleitet | BTIG Research | Buy |
| 2024-09-09 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-06-11 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-04-09 | Eingeleitet | Mizuho | Buy |
| 2023-03-29 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Enliven Therapeutics Inc Aktie (ELVN) Neueste Nachrichten
Sector ETF performance correlation with Enliven Therapeutics Inc.Analyst Upgrade & Free Expert Verified Stock Movement Alerts - Newser
Can machine learning forecast Enliven Therapeutics Inc. recoveryTrade Ideas & Growth Focused Entry Reports - Newser
Is Enliven Therapeutics Inc. forming a bottoming base2025 Growth vs Value & Weekly Watchlist for Hot Stocks - Newser
Will Enliven Therapeutics Inc. bounce back from current supportJuly 2025 Pullbacks & Daily Stock Momentum Reports - Newser
Visual trend scoring systems applied to Enliven Therapeutics Inc.Gap Down & Precise Buy Zone Tips - Newser
Applying Elliott Wave Theory to Enliven Therapeutics Inc.Gold Moves & Growth Focused Stock Pick Reports - Newser
Using data models to predict Enliven Therapeutics Inc. stock movement2025 Pullback Review & Accurate Intraday Trading Signals - Newser
Can Enliven Therapeutics Inc. hit a new high this monthJuly 2025 Outlook & Fast Entry High Yield Tips - Newser
How to interpret RSI for Enliven Therapeutics Inc. stockQuarterly Profit Summary & High Conviction Buy Zone Picks - Newser
Using Bollinger Bands to evaluate Enliven Therapeutics Inc.2025 Top Decliners & Free Risk Controlled Daily Trade Plans - Newser
Full technical analysis of Enliven Therapeutics Inc. stock2025 Market Overview & Daily Price Action Insights - Newser
Using data tools to time your Enliven Therapeutics Inc. exitJuly 2025 Decliners & Consistent Growth Equity Picks - Newser
Enliven Therapeutics Inc. stock outlook for YEARWeekly Investment Report & Weekly Watchlist of Top Performers - Newser
What recovery options are there for Enliven Therapeutics Inc.Weekly Profit Recap & Verified Trade Idea Suggestions - Newser
Can volume confirm reversal in Enliven Therapeutics Inc.Trend Reversal & Low Volatility Stock Recommendations - Newser
Can Enliven Therapeutics Inc. be recession proofJuly 2025 Gainers & Free Expert Approved Momentum Trade Ideas - khodrobank.com
Is Enliven Therapeutics Inc. forming a double bottomInflation Watch & Real-Time Stock Movement Alerts - khodrobank.com
How to monitor Enliven Therapeutics Inc. with trend dashboardsStock Surge & Long-Term Safe Investment Plans - Newser
Can Enliven Therapeutics Inc. weather a recession2025 Technical Patterns & Technical Pattern Alert System - khodrobank.com
Enliven Therapeutics Inc. stock retracement – recovery analysisJuly 2025 Levels & Real-Time Stock Entry Alerts - Newser
Risk vs reward if holding onto Enliven Therapeutics Inc.Portfolio Value Summary & AI Enhanced Market Trend Forecasts - Newser
Should I invest in Enliven Therapeutics Inc. before earningsJuly 2025 Drop Watch & Technical Entry and Exit Alerts - khodrobank.com
Will Enliven Therapeutics Inc. stock go up in YEAREntry Point & AI Enhanced Trading Alerts - khodrobank.com
Is Enliven Therapeutics Inc. stock risky to hold nowMarket Sentiment Review & Capital Efficient Trading Techniques - khodrobank.com
Smart tools for monitoring Enliven Therapeutics Inc.’s price actionDollar Strength & High Return Trade Opportunity Guides - Newser
How volatile is Enliven Therapeutics Inc. stock2025 Price Momentum & Growth Focused Stock Pick Reports - خودرو بانک
Visualizing Enliven Therapeutics Inc. stock with heatmapsJuly 2025 Opening Moves & Entry and Exit Point Strategies - Newser
Combining price and volume data for Enliven Therapeutics Inc.Weekly Stock Analysis & Low Risk Profit Maximizing Plans - Newser
Finanzdaten der Enliven Therapeutics Inc-Aktie (ELVN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Enliven Therapeutics Inc-Aktie (ELVN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Hohl Benjamin | CHIEF FINANCIAL OFFICER |
Aug 27 '25 |
Sale |
20.63 |
3,250 |
67,039 |
23,000 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):